Ticker > Company >

Fortis Healthcare share price

Fortis Healthcare Ltd.

NSE: FORTIS BSE: 532843 SECTOR: Hospital & Healthcare Services  2.03 L   638   133

801.30
+3.45 (0.43%)
BSE: Today, 10:33 AM

Price Summary

Today's High

₹ 804.2

Today's Low

₹ 790.85

52 Week High

₹ 813

52 Week Low

₹ 475.25

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

60494.8 Cr.

Enterprise Value

62223.93 Cr.

No. of Shares

75.5 Cr.

P/E

948.4

P/B

6.67

Face Value

₹ 10

Div. Yield

0.13 %

Book Value (TTM)

₹  120.19

CASH

49.45 Cr.

DEBT

1778.59 Cr.

Promoter Holding

31.17 %

EPS (TTM)

₹  0.84

Sales Growth

22.39%

ROE

0.7 %

ROCE

2.23%

Profit Growth

-68.02 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Fortis Healthcare Ltd.

SRL La-femme

Index Presence

The company is present in 25Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.39%
3 Year18.79%
5 Year15.55%

Profit Growth

1 Year-68.02%
3 Year89.58%
5 Year-34.1%

ROE%

1 Year0.7%
3 Year1.33%
5 Year0.78%

ROCE %

1 Year2.23%
3 Year2.67%
5 Year2.2%

Debt/Equity

0.196

Price to Cash Flow

181.11

Interest Cover Ratio

2.0254

CFO/PAT (5 Yr. Avg.)

2.4521079040015

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 31.17 0.00
Mar 2025 31.17 0.00
Dec 2024 31.17 0.00
Sep 2024 31.17 0.00
Jun 2024 31.17 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 18.7877863928583% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -527.2477 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.4521079040015.

 Limitations

  • Company has a poor ROE of 1.33056666666667% over the past 3 years.
  • Company has a poor ROCE of 2.67363333333333% over the past 3 years
  • The company is trading at a high PE of 948.4.
  • The company is trading at a high EV/EBITDA of 136.0503.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 307.48 333.4 357.15 366.87 388.47
Total Expenditure 238.18 275.46 297.3 300.11 317.51
Operating Profit 69.3 57.94 59.85 66.76 70.96
Other Income 32.5 35.43 104.17 33.96 24.99
Interest 18.44 16.84 16.32 26.51 51.91
Depreciation 25.85 26.03 27.41 28.96 30.52
Exceptional Items 32.1 0 -68.28 5.56 -52.42
Profit Before Tax 89.61 50.5 52.01 50.81 -38.9
Tax 21.28 23.67 12.38 11.25 3.33
Profit After Tax 68.33 26.83 39.63 39.56 -42.23
Adjusted EPS (Rs) 0.91 0.36 0.52 0.52 -0.56

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 632.87 862.61 1052.93 1181.42 1445.89
Total Expenditure 604.96 747.21 919.78 988.62 1190.38
Operating Profit 27.91 115.41 133.15 192.81 255.5
Other Income 191.98 134.09 149.58 143 198.55
Interest 141.45 129.58 106.24 81.92 111.58
Depreciation 110.77 112.63 115.88 100.98 112.92
Exceptional Items 56.46 -16.28 48.29 93.65 -115.14
Profit Before Tax 24.13 -8.99 108.88 246.56 114.41
Tax 19.93 4.26 12.64 47.11 50.63
Net Profit 4.2 -13.25 96.24 199.45 63.78
Adjusted EPS (Rs.) 0.06 -0.18 1.27 2.64 0.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 754.96 754.96 754.96 754.96 754.96
Total Reserves 8126.57 8113.61 8208.58 8332.21 8319.04
Borrowings 663.78 585.52 281.58 254.05 1738.19
Other N/C liabilities 732.48 682.92 556.38 522.29 479.05
Current liabilities 472.51 462.74 644.66 760.13 994.7
Total Liabilities 10750.31 10599.75 10558.48 10623.65 12285.94
Assets
Net Block 852.83 770.28 491.86 467.31 924.97
Capital WIP 6.32 6.33 2.67 259.38 42.32
Intangible WIP 0.42 0 0 0.82 0.07
Investments 8898.47 8845.29 8847.6 8834.04 10178.25
Loans & Advances 605.51 570.78 525.56 420.23 750.14
Other N/C Assets 1.31 1.38 256.36 0.37 0.25
Current Assets 385.44 405.69 434.42 641.5 389.93
Total Assets 10750.31 10599.75 10558.48 10623.65 12285.94
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 24.13 -8.99 108.88 246.56 114.41
Adjustment 24.6 123.55 27.6 -46.82 149.3
Changes in Assets & Liabilities -7.28 10.72 95.53 41.77 68.28
Tax Paid -9.5 -48.79 -33.64 -23.06 2.03
Operating Cash Flow 31.94 76.49 198.38 218.45 334.02
Investing Cash Flow 28.4 237.74 204.62 44.46 -1572.21
Financing Cash Flow 5.91 -319.83 -395.43 -245.35 1275.91
Net Cash Flow 66.26 -5.6 7.57 17.56 37.72

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 31.17 31.17 31.17 31.17 31.17
northern tk venture pte. ... - - - 31.17 31.17
northern tk venture pte.l... - - 31.17 - -
northern tk venture pte. ... - 31.17 - - -
northern tk venture pte l... 31.17 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 68.83 68.83 68.83 68.83 68.83
aditya birla sun life tru... 3.64 3.47 2.97 2.46 2.47
amansa holdings private l... 1.39 1.41 1.41 1.70 1.70
axis bank limited 1.19 1.19 1.19 1.19 1.19
axis elss tax saver fund - - - - 3.40
dsp nifty healthcare etf - - - - 1.29
edelweiss business cycle ... - - - - 1.01
fidelity funds - india fo... - 1.67 - 1.62 1.64
government pension fund g... - 1.23 1.14 - 1.04
hdfc mutual fund-hdfc arb... - - - - 5.68
jupiter india fund 1.85 1.86 1.81 1.52 1.38
kotak equity hybrid - - - - 5.14
kotak funds - india midca... 1.25 1.28 - 1.24 1.24
nippon life india trustee... - - - - 2.38
rekha jhunjhunwala 4.21 4.07 4.07 4.07 4.07
sbi life insurance co. lt... - - - 1.53 1.55
axis mutual fund trustee ... 3.15 3.29 3.46 3.40 -
dsp equity opportunities ... - - - 1.29 -
hdfc mutual fund - hdfc s... - - 5.86 6.00 -
kotak emerging equity sch... - - - 4.56 -
mirae asset nifty midcap ... - 1.77 - 1.33 -
nippon life india trustee... - 2.37 - 2.28 -
fidelity funds-india focu... 1.67 - 1.72 - -
kotak funds-india midcap ... - - 1.27 - -
kotak mahindra trustee co... - - 4.40 - -
mire asset elss tax saver... - - 1.54 - -
nippon life india trustee... - - 2.40 - -
sbi life insurance co.ltd... 2.47 1.42 1.40 - -
sbi long term equity fund... - 1.11 1.15 - -
hdfc mutual fund - hdfc n... - 5.56 - - -
kotak mahindra trustee co... - 5.28 - - -
sundaram mutual fund a/c ... - 1.13 - - -
hdfc mutual fund - hdfc b... 5.19 - - - -
kotak mahindra trustee co... 4.47 - - - -
mirae asset midcap fund 2.99 - - - -
nippon india trustee ltd-... 2.43 - - - -
sbi large & midcap fund 1.49 - - - -
sundaram mutual fund a/c ... 1.23 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Ventura
Research Way2Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY23
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY20
Concall Q2FY24
Concall Q2FY21
Concall Q1FY25
Concall Q1FY24
Concall Q1FY21
Concall Q1FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY20
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY24
Presentation Q1FY21
Presentation Q1FY20

Company News

Fortis Healthcare informs about dividend payment 14 Jul, 5:37 PM Fortis Healthcare reports 7% fall in Q4 consolidated net profit 21 May, 2:23 PM Fortis Healthcare - Quaterly Results 20 May, 7:19 PM Fortis Healthcare - Quaterly Results 20 May, 7:19 PM Fortis Healthcare informs about reporting of debt securities 10 Apr, 11:54 AM Fortis Healthcare’s arm to acquire entire business operations of Shrimann Superspecialty Hospital 14 Feb, 4:25 PM Fortis Healthcare - Quaterly Results 7 Feb, 6:00 PM Fortis Healthcare - Quaterly Results 7 Feb, 6:00 PM Fortis Healthcare acquires 7.61% stake in Agilus Diagnostics 21 Dec, 12:29 PM Fortis Healthcare informs about outcome of committee meeting 19 Dec, 4:34 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare informs about change in directorate 23 Sep, 12:13 PM Fortis Healthcare informs about earnings call transcript 12 Aug, 1:32 PM Fortis Healthcare informs about disclosure 7 Aug, 12:14 PM Fortis Healthcare - Quaterly Results 6 Aug, 8:22 PM Fortis Healthcare - Quaterly Results 6 Aug, 8:22 PM Fortis Healthcare reports 47% rise in Q4 consolidated net profit 24 May, 2:26 PM Fortis Healthcare - Quaterly Results 23 May, 7:10 PM Fortis Healthcare - Quaterly Results 23 May, 7:10 PM Fortis Healthcare informs about disclosure 23 Feb, 5:21 PM Fortis Healthcare - Quaterly Results 7 Feb, 7:45 PM Fortis Healthcare - Quaterly Results 7 Feb, 7:45 PM Fortis Healthcare’s arm sells business operations in Chennai to MGM 2 Feb, 11:45 AM Fortis Healthcare reports 16% fall in Q2 consolidated net profit 13 Nov, 12:42 PM Fortis Healthcare - Quaterly Results 10 Nov, 6:30 PM Fortis Healthcare - Quaterly Results 10 Nov, 6:30 PM Fortis Healthcare informs about disclosure 30 Sep, 10:33 AM Fortis Healthcare informs about change in directorate 13 Sep, 5:14 PM Fortis Healthcare informs about voting results 8 Sep, 5:11 PM Fortis Healthcare - Quaterly Results 4 Aug, 8:06 PM Fortis Healthcare - Quaterly Results 4 Aug, 8:06 PM Fortis Healthcare partners with emergency response network RED.Health 27 Jun, 3:07 PM Fortis Healthcare inks pact for sale of hospital business operations at Vadapalani 22 Jun, 3:42 PM Fortis Healthcare informs about investor meetings 5 Jun, 12:48 PM Fortis Healthcare informs about disclosure 1 Jun, 4:18 PM Fortis Healthcare reports 59% rise in Q4 consolidated net profit 24 May, 11:14 AM Fortis Healthcare - Quaterly Results 23 May, 9:12 PM Fortis Healthcare - Quaterly Results 23 May, 9:12 PM Fortis Healthcare signs definitive agreements for acquisition of Medeor Hospital in Manesar 20 Apr, 2:30 PM Fortis Healthcare - Quaterly Results 10 Feb, 7:51 PM Fortis Healthcare - Quaterly Results 10 Feb, 7:51 PM Fortis Healthcare informs about closure of trading window 29 Dec, 4:49 PM Fortis Healthcare reports 67% rise in Q2 consolidated net profit 12 Nov, 12:55 PM Fortis Healthcare - Quaterly Results 11 Nov, 6:15 PM Fortis Healthcare - Quaterly Results 11 Nov, 6:15 PM Fortis Healthcare informs about analyst meet 22 Aug, 1:00 PM Fortis Healthcare reports 69% fall in Q1 consolidated net profit 6 Aug, 11:14 AM Fortis Healthcare - Quaterly Results 5 Aug, 8:44 PM

Fortis Healthcare Stock Price Analysis and Quick Research Report. Is Fortis Healthcare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Fortis Healthcare and its performance over the period of time. Fortis Healthcare stock price today is Rs 801.1.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Fortis Healthcare cash from the operating activity was Rs 334.02 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Fortis Healthcare has a Debt to Equity ratio of 0.196 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Fortis Healthcare , the EPS growth was -68.0192 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Fortis Healthcare has OPM of 17.6710717866564 % which is a good sign for profitability.
     
  • ROE: Fortis Healthcare have a poor ROE of 0.7024 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Fortis Healthcare is Rs 801.1. One can use valuation calculators of ticker to know if Fortis Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Fortis Healthcare

Fortis Healthcare Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

 

Fortis Healthcare Ltd. is a leading healthcare provider in India that offers a wide range of medical services. As a long-term stock investor, it is important to understand the company's financial health and performance to make informed investment decisions.  We will analyze Fortis Healthcare Ltd.'s stock using various parameters such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Fortis Healthcare Ltd Share Price

Fortis Healthcare Ltd.'s share price has seen a steady rise in the past few years. The company's share price has been hovering around Rs. 200-250 in the last year. However, it is important to note that the share price can be volatile in the short term and investors should focus on long-term trends.

Fortis Healthcare Ltd Balance Sheet

Fortis Healthcare Ltd.'s balance sheet shows a healthy financial position. The company has a strong asset base and a low debt-to-equity ratio. The company's pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can be used to calculate the fair value of the stock.

Fortis Healthcare Ltd Annual Report

Fortis Healthcare Ltd.'s annual report provides a detailed overview of the company's financial performance, business strategy, and future plans. The annual report is available for download on Ticker. Investors can use the information in the annual report to make informed investment decisions.

Fortis Healthcare Ltd Dividend

Fortis Healthcare Ltd. has a consistent dividend payout history. The company has been paying dividends regularly for the past few years. However, it is important to note that the dividend payout can be affected by various factors such as the company's financial performance, future plans, and market conditions.

Fortis Healthcare Ltd Quarterly Result

Fortis Healthcare Ltd.'s quarterly results provide a snapshot of the company's financial performance in the short term. The company's pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can be used to analyze the quarterly results.

Fortis Healthcare Ltd Stock Price

Fortis Healthcare Ltd.'s stock price can be affected by various factors such as the company's financial performance, market conditions, and investor sentiment. It is important to focus on long-term trends and use pre-built screening tools to analyze the stock price.

Fortis Healthcare Ltd Price Chart

Fortis Healthcare Ltd.'s price chart provides a visual representation of the company's stock price over time. The price chart can be used to identify long-term trends and patterns in the stock price.

Fortis Healthcare Ltd News

Fortis Healthcare Ltd.'s news section provides the latest updates about the company's financial performance, business strategy, and future plans. Investors can use the news section to stay updated about the company's developments.

Fortis Healthcare Ltd Concall

Fortis Healthcare Ltd.'s concall provides an opportunity for investors to interact with the company's management and ask questions about the company's financial performance, business strategy, and future plans. Investors can use the concall to get a better understanding of the company's operations.

Fortis Healthcare Ltd Transcripts

Fortis Healthcare Ltd.'s transcripts provide a detailed record of the company's concall. The transcripts can be used to analyze the company's responses to investors' questions and get a better understanding of the company's operations.

Fortis Healthcare Ltd Investor Presentations

Fortis Healthcare Ltd.'s investor presentations provide a detailed overview of the company's financial performance, business strategy, and future plans. The investor presentations can be used to make informed investment decisions.

Fortis Healthcare Ltd Promoters

Fortis Healthcare Ltd.'s promoters are the individuals or entities that hold a significant stake in the company. The promoters play a key role in the company's decision-making process and can influence the company's operations.

Fortis Healthcare Ltd Shareholders

Fortis Healthcare Ltd.'s shareholders are the individuals or entities that hold a stake in the company. The shareholders can influence the company's decision-making process through voting rights and can benefit from the company's financial performance through dividends and capital appreciation.

Fortis Healthcare Ltd ROCE

Fortis Healthcare Ltd ROCE (Return on Capital Employed) is a financial metric that assesses the company's effectiveness in generating profits from its capital investments. By analyzing the ROCE data for Fortis Healthcare Ltd available on this page, investors can evaluate the company's capital utilization and profitability. Detailed ROCE data can be found in the financials table or ratio section provided above.

Fortis Healthcare Ltd EBITDA

Fortis Healthcare Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a key metric that helps understand the company's operational profitability. By excluding non-operating expenses, EBITDA provides insights into the core business performance of Fortis Healthcare Ltd. Investors can access the EBITDA data for the company in the financials table or ratio section above.

Fortis Healthcare Ltd DPS

Fortis Healthcare Ltd DPS (Dividends Per Share) represents the cash distributed to shareholders for each share held in the company. Understanding the DPS data helps investors evaluate the company's dividend policy and potential returns. Detailed DPS information for Fortis Healthcare Ltd can be found in the financials table or ratio section available above.

Fortis Healthcare Ltd EPS

Fortis Healthcare Ltd EPS (Earnings Per Share) is a crucial metric that indicates the company's profitability on a per-share basis. By analyzing the EPS data, investors can assess the company's earning potential and performance. Access the detailed EPS data for Fortis Healthcare Ltd in the financials table or ratio section provided above. 

Fortis Healthcare Equity and Liabilities Review

Fortis Healthcare Share Capital

Fortis Healthcare's share capital remains constant over five years from Mar 2020 to Mar 2024 at Rs 754.96 Cr., indicating no additional equity dilution.

Fortis Healthcare Total Reserves

Total reserves of Fortis Healthcare showed a gradual increase from Rs 8,121.51 Cr. in Mar 2020 to Rs 8,332.21 Cr. in Mar 2024, portraying a steady internal growth.

Fortis Healthcare Borrowings

The company's borrowings have significantly dropped from Rs 621.35 Cr. in Mar 2020 to Rs 254.05 Cr. in Mar 2024, showcasing a strong focus on debt reduction.

Fortis Healthcare Current Liabilities

An increasing trend in current liabilities from Rs 468.51 Cr. in Mar 2020 to Rs 760.13 Cr. in Mar 2024 indicates a rise in short-term obligations.

Fortis Healthcare Assets Analysis

Fortis Healthcare Investments

Investments have seen a nominal increase from Rs 8,153.11 Cr. in Mar 2020 to Rs 8,834.04 Cr. in Mar 2024, signifying a stable investment strategy.

Fortis Healthcare Net Block and Capital WIP

A significant decrease in Net Block combined with an unusual rise in Capital WIP in Mar 2024 to Rs 259.38 Cr. suggests a potential phase of expansion or asset upgrade.

Fortis Healthcare Current Assets

Current assets observed a robust increase, potentially underlining a growth in operational efficiency or inventory.

This data is an analysis for the Standalone Balance sheet of the company.

Fortis Healthcare plays a pivotal role in the healthcare sector; investors may also explore similar sectors for diversification in their portfolio.

Read More
X